6
Tetrahedron
5
6
3q
3q
12
10
79
80
4e
4a
5e
5f
7
3q
15
88
4f
5g
Reaction conditions: benzo[d]benzo[4,5]imidazo[2,1-b]thiazole (0.3 mmol, 1 equiv), arylboronic acid (0.45 mmol, 1.5 equiv),
a
Pd(PPh3)4 (0.1 mmol, 10 mol%), and K2CO3 (0.45 mmol, 1.5 equiv) in dioxane/H2O (6 mL, 5:1, v:v) under N2 at 100 °C.
b Isolated yield.
S.; Marinelli, L.; Novellino, E.; Chiarini, A. J. Med. Chem. 2008,
51, 1592-1600.
The derivation of the halo benzimidazo[2,1-b]benzothiazoles
is also feasible. We found that under proper Pd catalysis, several
bromo-containing products could smoothly react with
arylboronic acids to afford the corresponding arylated
benzimidazo[2,1- b]benzothiazole derivatives (Table 4, entries 1-
7).17 As a novel class of imidazo[2,1-b]benzothiazole derivatives,
these polycyclic molecules possess unprecedented structural
features and might be of particular biological interest.
5. Several imidazo[2,1-b]benzothiazoles have been reported as
potential drugs with antineuropathic, antimicrobial, and anticancer
activities. For examples, see: (a) Yousefi, B. H.; Manook, A.;
Drzezga, A.; Reutern, B.; Schwaiger, M.; Wester, H. J.;
Henriksen, G. J. Med. Chem. 2011, 54, 949-956. (b) Malik, J. K.;
Noolvi, M. N.; Manvi, F. V.; Nanjwade, B. K.; Patel, H. M.;
Manjula, S. N.; Rao, C. M.; Barve, A. Lett. Drug Des. Discov.
2011, 8, 717-724. (c) Al-Tel, T. H.; Al-Qawasmeh, R. A.;
Zaarour, R. Eur. J. Org. Chem. 2011, 46, 1874-1881. (d) Palkar,
M.; Noolvi, M.; Sankangoud, R.; Maddi, V.; Gadad, A.; Nargund,
L. V. G. Arch. Pharm. 2010, 343, 353-359.
In summary, we have described an efficient and convenient
approach to benzimidazo[2,1-b]benzothiazoles through Cu-
catalyzed domino reactions. A variety of o-dihaloarenes and 2-
mercaptobenzimidazoles with electron-donating and electron-
withdrawing substituents smoothly gave the desired products.
Moreover, tri-functionalized substrates selectively delivered the
halo-containing benzimidazo[2,1-b]benzothiazoles, and the
brominated ones successfully reacted with arylboronic acids
under Pd catalysis to give the corresponding aryl
6. Lin, D. C. K.; DeJongh, D. C. J. Org. Chem. 1974, 39, 1780-1782.
7. D’Amico, J. J.; Tung, C. C.; Dahl, W. E. J. Org. Chem. 1977, 42,
600-602.
8. Zhang, X. H.; Jia, J.; Ma, C. Org. Biomol. Chem. 2012, 10, 7944-
7948.
9. For selected reviews, see: (a) Beletskaya, I. P.; Ananikov, V. P.
Chem. Rev. 2011, 111, 1596-1636. (b) Carril, M.; SanMartin, R.;
Dominguez, E. Chem. Soc. Rev. 2008, 37, 639-647. (c) de
Meijere, A., Diederich, F., Eds. Metal-Catalyzed Cross-Coupling
Reactions, 2nd. Wiley-VCH: Weinheim, Germany, 2004.
10. For selected recent reviews, see: (a) Surry, D. S.; Buchwald, S. L.
Chem. Sci. 2010, 1, 13-31. (b) Monnier, F.; Taillefer, M. Angew.
Chem. Int. Ed. 2009, 48, 6954-6971. (c) Ma, D. W.; Cai, Q. Acc.
Chem. Res. 2008, 41, 1450-1460. (d) Evano, G.; Blanchard, N.;
Toumi, M. Chem. Rev. 2008, 108, 3054-3131.
benzo[d]benzo[4,5]imidazo[2,1-b]thiazole
derivatives.
The
methodology may be practical and useful for the synthesis of
related heterocyclic compounds of biological and medicinal
interests.
Acknowledgments
11. For reviews, see: (a) Liu, Y.; Wan, J. –P. Chem. Asian J. 2012, 7,
1488-1501. (b) Liu, Y.; Wan, J. –P. Org. Biomol. Chem. 2011, 9,
6873-6894.
This work was financially supported by the National Natural
Science Foundation of China (No. 21202152) and the Zhejiang
Provincial Natural Science Foundation (No. Y4110044).
12. Wu, Z. Q.; Huang, Q.; Zhou, X. G.; Yu, L. T.; Li, Z. K.; Wu, D.
Eur. J. Org. Chem. 2011, 5242-5245.
13. During the preparation of this manuscript, Abele et al. reported the
synthesis of the fused imidazo[2,1-b]benzothiazoles from o-
dihaloarenes and 2-mercaptoimidazoles using phase-transfer
catalytic system: (a) Abele, E.; Beresneva, T. Heterocycl. Lett.
2013, 3, 397-401. (b) Beresneva, T.; Abele, E. Chem. Heterocycl.
Comp. 2013, 49, 345-347.
References and notes
1. (a) Park, J. –H.; El-Gamal, M. I.; Lee, Y. S.; Oh, C. –H. Eur. J.
Med. Chem. 2011, 46, 5769-5777. (b) Andreani, A.; Burnelli, S.;
Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.;
Varoli, L.; Calonghi, N.; Cappadone, C.; Farruggia, G.; Zini, M.;
Stefanelli, C.; Masotti, L.; Radin, N. S.; Shoemaker, R. H. J. Med.
Chem. 2008, 51, 809-816. (c) Andreani, A.; Rambaldi, M.; Leoni,
A.; Locatelli, A.; Bossa, R.; Fraccari, A.; Galatulas, I.; Salvatore,
G. J. Med. Chem. 1996, 39, 2852-2855. (d) Andreani, A.;
Rambaldi, M.; Locatelli, A.; Bossa, R.; Fraccari, A.; Galatulas, I.;
J. Med. Chem. 1992, 35, 4634-4637.
14. (a) Yuan, G.; Liu, H.; Gao, J.; Yang, K.; Niu, Q.; Mao, H.; Wang,
X.; Lv, X.; J. Org. Chem. 2014, 79, 1749-1757. (b) Niu, Q.; Mao,
H.; Yuan, G.; Gao, J.; Liu, H.; Tu, Y.; Wang, X.; Lv, X. Adv.
Synth. Catal. 2013, 355, 1185-1192. (c) Xia, Z.; Wang, K.; Zheng,
J.; Ma, Z.; Jiang, Z.; Wang, X.; Lv, X. Org. Biomol. Chem. 2012,
10, 1602-1611.
15. General procedure for Cu-catalyzed one-pot synthesis of
benzimidazo[2,1-b]benzothiazoles. An oven-dried Schlenk tube
was charged with a magnetic stir bar, binucleophile 2-
mercaptobenzimidazole 2 (1.0 mmol, 1.0 equiv), CuI (0.1 mmol,
10 mol %), phen (0.2 mmol, 20 mol %), and K2CO3 (2.0 mmol, 2
equiv). The tube was capped and then evacuated and backfilled
with nitrogen (3 times). Under a positive pressure of nitrogen, a
solution of o-dihaloarene 1 (1.05 mmol, 1.05 equiv) in DMF (3
mL) was added via syringe. The tube was sealed and allowed to
stir at 120 °C (monitored by TLC). After being cooled to room
temperature, EtOAc (40 mL) was added and the mixture was
washed with brine (20 mL × 3). The organic phase was dried over
Na2SO4 and concentrated. The residue was purified by column
2. Vu, C. B.; Bemis, J. E.; Disch, J. S.; Ng, P. Y.; Nunes, J. J.; Milne,
J. C.; Carney, D. P.; Lynch, A. V.; Smith, J. J.; Lavu, S.; Lambert,
P. D.; Gagne, D. J.; Jirousek, M. R.; Schenk, S.; Olefsky, J. M.;
Perni, R. B. J. Med. Chem. 2009, 52, 1275-1283.
3. Moraski, G. C.; Markley, L. D.; Chang, M.; Cho, S.; Franzblau, S.
G.; Hwang, C. H.; Boshoff, H.; Miller, M. J. Boorg. Med. Chem.
2012, 20, 2214-2220.
4. (a) Locatelli, A.; Cosconati, S.; Micucci, M.; Leoni, A.; Marinelli,
L.; Bedini, A.; Loan, P.; Spampinato, S. M.; Novellino, E.;
Chiarini, A.; Budriesi, R. J. Med. Chem. 2013, 56, 3866-3877. (b)
Budriesi, R.; Ioan, P.; Locatelli, A.; Cosconati, S.; Leoni, A.;
Ugenti, M. P.; Andreani, A.; Toro, R. D.; Bedini, A.; Spampinato,